Telephone
61.3.8681.4050
Address
Unit 2 320 Lorimer Street Port Melbourne, Victoria (VIC) 3207
Description
Polynovo Ltd. engages in the provision biodegradable medical devices. It focuses on biodegradable temporizing matrix (BTM) product. It operates through the United States of America, and Australia and New Zealand geographical segment. The company was founded on August 12, 1998 and is headquartered in Port Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.1 - 2.71
Trade Value (12mth)
AU$820,208.00
1 week
1.85%
1 month
14.58%
YTD
-32.6%
1 year
-32.27%
All time high
4.08
EPS 3 yr Growth
14.300%
EBITDA Margin
-6.00%
Operating Cashflow
-$6m
Free Cash Flow Return
-11.10%
ROIC
-9.30%
Interest Coverage
-5.50
Quick Ratio
5.00
Shares on Issue (Fully Dilluted)
690m
HALO Sector
Healthcare
Next Company Report Date
22-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
5.12
Date | Announcements |
---|---|
31 May 23 |
Notification regarding unquoted securities - PNV
×
Notification regarding unquoted securities - PNV |
31 March 23 |
Application for quotation of securities - PNV
×
Application for quotation of securities - PNV |
31 August 23 |
Webcast Recording - FY23 Results
×
Webcast Recording - FY23 Results |
30 September 10 |
Annual Report and Full Year Financial Accounts (CZD-AU)
×
Annual Report and Full Year Financial Accounts (CZD-AU) |
30 November 22 |
Share Purchase Plan (SPP) Offer
×
Share Purchase Plan (SPP) Offer |
30 June 23 |
Appendix 3Y - Robyn Elliott
×
Appendix 3Y - Robyn Elliott |
29 October 15 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
29 October 15 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 November 22 |
Cleansing Notice
×
Cleansing Notice |
29 July 22 |
CEO Appointment - Swami Raote
×
CEO Appointment - Swami Raote |
28 September 07 |
2007 Annual Report and Notice of AGM (MBP-AU)
×
2007 Annual Report and Notice of AGM (MBP-AU) |
28 September 06 |
CEO presents at UBS Global Life Sciences Conference (NY)
×
CEO presents at UBS Global Life Sciences Conference (NY) |
28 October 22 |
Chairman and CEO - AGM address to shareholders
×
Chairman and CEO - AGM address to shareholders |
28 October 22 |
Results of 2022 Annual General Meeting
×
Results of 2022 Annual General Meeting |
28 October 08 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
28 November 22 |
Application for quotation of securities - PNV
×
Application for quotation of securities - PNV |
27 September 22 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
27 October 06 |
Metabolic Pharmaceuticals Limited - CEO presentation
×
Metabolic Pharmaceuticals Limited - CEO presentation |
27 November 08 |
AGM Presentation
×
AGM Presentation |
27 November 06 |
Corporate Presentation for Domestic Roadshow
×
Corporate Presentation for Domestic Roadshow |
27 May 22 |
Director Share Purchase - David Williams
×
Director Share Purchase - David Williams |
27 June 22 |
Ceasing to be a substantial holder from MUFG
×
Ceasing to be a substantial holder from MUFG |
26 September 08 |
Annual Report to shareholders
×
Annual Report to shareholders |
26 September 06 |
Annual Report/Notice of AGM
×
Annual Report/Notice of AGM |
26 October 23 |
PolyNovo presents at Wilsons Drug and Device Conference
×
PolyNovo presents at Wilsons Drug and Device Conference |
26 October 22 |
Hong Kong - Two cases, Two surgeons
×
Hong Kong - Two cases, Two surgeons |
26 October 21 |
Results of 2021 Annual General Meeting
×
Results of 2021 Annual General Meeting |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.